Luke Jonathan Grauke, MD - Medicare Diagnostic Radiology in Lewiston, ID

Luke Jonathan Grauke, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in Lewiston, Idaho. He went to University Of Washington School Of Medicine and graduated in 2007 and has 17 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Benewah Community Hospital, Bonner General Hospital Inc, Boundary Community Hospital, Kootenai Health Inc, Kootenai Health, Inc., Radiology Associates Of North Idaho Pa and his current practice location is 531 4th Ave, Lewiston, Idaho. You can reach out to his office (for appointments etc.) via phone at (208) 743-4393.

Luke Jonathan Grauke is licensed to practice in Idaho (license number M-11990) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1972751709.

Contact Information

Luke Jonathan Grauke, MD
531 4th Ave,
Lewiston, ID 83501-2450
(208) 743-4393
(208) 743-4214



Physician's Profile

Full NameLuke Jonathan Grauke
GenderMale
SpecialityDiagnostic Radiology
Experience17 Years
Location531 4th Ave, Lewiston, Idaho
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Luke Jonathan Grauke attended and graduated from University Of Washington School Of Medicine in 2007
  NPI Data:
  • NPI Number: 1972751709
  • Provider Enumeration Date: 09/04/2008
  • Last Update Date: 03/13/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 9638333933
  • Enrollment ID: I20130920000188

Medical Identifiers

Medical identifiers for Luke Jonathan Grauke such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1972751709NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology M-11990 (Idaho)Primary
2085R0202XRadiology - Diagnostic Radiology MD60108172 (Washington)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Kootenai HealthCoeur d'alene, IDHospital
Northwest Specialty HospitalPost falls, IDHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Benewah Community Hospital185020070019
Bonner General Hospital Inc408269046636
Boundary Community Hospital327458340621
Kootenai Health Inc1355792276291
Kootenai Health, Inc.4789641598331
Radiology Associates Of North Idaho Pa438563515022

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Luke Jonathan Grauke allows following entities to bill medicare on his behalf.
Entity NameRadiology Associates Of North Idaho Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851384416
PECOS PAC ID: 4385635150
Enrollment ID: O20040520000648

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameBonner General Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154563963
PECOS PAC ID: 4082690466
Enrollment ID: O20040626000014

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameBenewah Community Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1386632180
PECOS PAC ID: 1850200700
Enrollment ID: O20040927000265

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameKootenai Health, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1235288655
PECOS PAC ID: 4789641598
Enrollment ID: O20041214000230

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameBoundary Community Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801896683
PECOS PAC ID: 3274583406
Enrollment ID: O20050126000312

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameBenewah Community Hospital
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1548320435
PECOS PAC ID: 1850200700
Enrollment ID: O20061104000136

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameSmi Imaging Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972004489
PECOS PAC ID: 3476696220
Enrollment ID: O20230327002416

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameSimonmed Imaging Florida Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477830818
PECOS PAC ID: 6608036108
Enrollment ID: O20230517000514

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Entity NameKootenai Health Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174661151
PECOS PAC ID: 1355792276
Enrollment ID: O20240111003252

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Luke Jonathan Grauke is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Luke Jonathan Grauke, MD
531 4th Ave,
Lewiston, ID 83501-2450

Ph: (208) 743-4393
Luke Jonathan Grauke, MD
531 4th Ave,
Lewiston, ID 83501-2450

Ph: (208) 743-4393

News Archive

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

Turmeric back in the fight against cancer

Scientists have known for some time that turmeric, a key flavour in Indian curry, has anti-cancer properties.

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

Read more News

› Verified 8 days ago


Radiology Doctors in Lewiston, ID

Dr. John W. Ho, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 415 6th St, Lewiston, ID 83501
Phone: 208-750-7445    
Dr. Khadijeh S. Zarkoob, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 504 6th St, Lewiston, ID 83501
Phone: 208-799-5600    
Dr. Mark W Peterson, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 415 6th St, Lewiston, ID 83501
Phone: 208-799-5335    
Dr. Michael Todd Burtis, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 531 4th Ave, Lewiston, ID 83501
Phone: 208-743-4393    
Norman Robert Willis, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 504 6th St, Lewiston, ID 83501
Phone: 208-799-5600    Fax: 208-799-5755
Dr. Gregory Robert Spurling, M.D
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 531 4th Ave, Lewiston, ID 83501
Phone: 208-743-4393    
Dr. Michael E Bell, M.D.
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 415 6th St, Lewiston, ID 83501
Phone: 208-799-5335    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.